The solution structure of the human IgG2 subclass is distinct from those for human IgG1 and IgG4 providing an explanation for their discrete functions.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
12 07 2019
Historique:
received: 12 12 2018
revised: 03 05 2019
pubmed: 16 5 2019
medline: 4 3 2020
entrez: 16 5 2019
Statut: ppublish

Résumé

Human IgG2 antibody displays distinct therapeutically-useful properties compared with the IgG1, IgG3, and IgG4 antibody subclasses. IgG2 is the second most abundant IgG subclass, being able to bind human FcγRII/FcγRIII but not to FcγRI or complement C1q. Structural information on IgG2 is limited by the absence of a full-length crystal structure for this. To this end, we determined the solution structure of human myeloma IgG2 by atomistic X-ray and neutron-scattering modeling. Analytical ultracentrifugation disclosed that IgG2 is monomeric with a sedimentation coefficient (

Identifiants

pubmed: 31088911
pii: S0021-9258(20)30183-6
doi: 10.1074/jbc.RA118.007134
pmc: PMC6635440
pii:
doi:

Substances chimiques

Carrier Proteins 0
Immunoglobulin Fab Fragments 0
Immunoglobulin Fc Fragments 0
Immunoglobulin G 0
prolactin-binding protein 0

Banques de données

PDB
['1HZH', '5DK3', '1IGT', '6FCZ', '4X4M', '3SGJ', '5VU0', '5YC5', '3KYM', '4HAF']

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

10789-10806

Informations de copyright

© 2019 Hui et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest with the contents of this article.

Références

Chem Rev. 2001 Jun;101(6):1763-78
pubmed: 11709998
Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):833-8
pubmed: 25561553
Biophys J. 2011 Aug 17;101(4):892-8
pubmed: 21843480
Adv Exp Med Biol. 2017;1009:47-64
pubmed: 29218553
MAbs. 2010 May-Jun;2(3):212-20
pubmed: 20400859
Biophys J. 1998 Sep;75(3):1503-12
pubmed: 9726952
J Phys Chem B. 2013 Nov 14;117(45):14029-38
pubmed: 24171386
Biochemistry. 1973 Nov 20;12(24):4998-5005
pubmed: 4796922
Int J Mass Spectrom. 2013 Jul 1;345-347:54-62
pubmed: 25844045
Mol Immunol. 2013 Nov;56(1-2):131-9
pubmed: 23628091
J Immunol. 2003 Mar 15;170(6):3134-8
pubmed: 12626570
J Phys Chem B. 2010 Oct 14;114(40):12981-94
pubmed: 20845956
Anal Chem. 2010 Feb 1;82(3):1090-9
pubmed: 20039682
Biophys J. 2000 Mar;78(3):1606-19
pubmed: 10692345
J Biol Chem. 2008 Jun 6;283(23):16194-205
pubmed: 18339624
Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12669-74
pubmed: 21768335
ACS Chem Biol. 2018 Aug 17;13(8):2179-2189
pubmed: 30016589
J Immunol. 2001 May 15;166(10):6250-6
pubmed: 11342648
Pharm Res. 2012 Aug;29(8):2225-35
pubmed: 22477029
J Comput Chem. 2004 Aug;25(11):1400-15
pubmed: 15185334
Mol Immunol. 1987 Aug;24(8):821-9
pubmed: 3657808
J Synchrotron Radiat. 2009 Nov;16(Pt 6):872-9
pubmed: 19844027
Methods. 2014 Jan 1;65(1):114-26
pubmed: 23872058
Biochemistry. 2015 Mar 17;54(10):1956-62
pubmed: 25730439
Mol Immunol. 1994 Oct;31(15):1201-10
pubmed: 7935507
MAbs. 2012 Jan-Feb;4(1):17-23
pubmed: 22327427
J Mol Biol. 1983 Aug 25;168(4):847-66
pubmed: 6310128
J Chem Theory Comput. 2009 Aug 20;5(9):2353-2370
pubmed: 20161005
J Appl Crystallogr. 2015 May 09;48(Pt 3):953-961
pubmed: 26089768
J Synchrotron Radiat. 2013 Jul;20(Pt 4):660-4
pubmed: 23765312
Sci Rep. 2018 Mar 2;8(1):3955
pubmed: 29500371
Clin Exp Immunol. 1993 Nov;94(2):291-6
pubmed: 8222320
Protein Sci. 2010 May;19(5):954-66
pubmed: 20198683
J Phys Chem B. 1998 Apr 30;102(18):3586-616
pubmed: 24889800
EMBO J. 1988 Jul;7(7):1989-94
pubmed: 3138110
Eur J Biochem. 1985 Feb 15;147(1):17-25
pubmed: 3971974
Biophys Chem. 2017 Dec;231:45-49
pubmed: 28622937
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
PLoS One. 2013 Jun 07;8(6):e64076
pubmed: 23762236
Nat Struct Mol Biol. 2015 Dec;22(12):953-8
pubmed: 26595420
IUCrJ. 2015 Jan 01;2(Pt 1):9-18
pubmed: 25610623
J Comput Chem. 2011 Nov 15;32(14):3135-41
pubmed: 21815173
J Appl Crystallogr. 2016 Oct 14;49(Pt 6):1861-1875
pubmed: 27980506
J Biol Chem. 2014 Jul 25;289(30):20740-56
pubmed: 24876381
Biophys Chem. 2001 Nov 28;93(2-3):129-39
pubmed: 11804721
Science. 2001 Aug 10;293(5532):1155-9
pubmed: 11498595
N Engl J Med. 1980 Jul 24;303(4):178-82
pubmed: 6966763
Acta Crystallogr D Biol Crystallogr. 2015 Jan 1;71(Pt 1):67-75
pubmed: 25615861
Eur J Biochem. 1986 May 15;157(1):169-80
pubmed: 3709531
J Pharm Sci. 2014 Jun;103(6):1701-10
pubmed: 24700358
Science. 2018 Feb 16;359(6377):794-797
pubmed: 29449492
J Chem Theory Comput. 2012 Sep 11;8(9):3257-3273
pubmed: 23341755
Biochemistry. 1981 Apr 28;20(9):2361-70
pubmed: 7236608
Eur J Pharm Biopharm. 2017 Mar;112:132-137
pubmed: 27890509
Clin Exp Immunol. 1986 Jan;63(1):127-34
pubmed: 3955880
Proc Natl Acad Sci U S A. 1969 May;63(1):78-85
pubmed: 5257969
Acta Crystallogr D Biol Crystallogr. 2015 Jan 1;71(Pt 1):76-85
pubmed: 25615862
MAbs. 2011 Nov-Dec;3(6):558-67
pubmed: 22123056
Biochemistry. 2008 Jul 15;47(28):7496-508
pubmed: 18549248
PLoS One. 2015 May 21;10(5):e0126420
pubmed: 25997164
J Biol Chem. 2008 Jun 6;283(23):16206-15
pubmed: 18339626
J Biol Chem. 2015 Mar 27;290(13):8420-38
pubmed: 25659433
J Appl Crystallogr. 2012 Mar 15;45(Pt 2):342-350
pubmed: 25484842
J Biol Chem. 2008 Oct 24;283(43):29266-72
pubmed: 18713741
Protein Sci. 2010 Apr;19(4):753-62
pubmed: 20120022
Protein Sci. 2010 Sep;19(9):1601-15
pubmed: 20556807
Adv Exp Med Biol. 2017;1009:107-129
pubmed: 29218556
Blood. 2009 Apr 16;113(16):3716-25
pubmed: 19018092

Auteurs

Gar Kay Hui (GK)

Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, WC1E 6BT, United Kingdom.

Antoni D Gardener (AD)

Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, WC1E 6BT, United Kingdom.

Halima Begum (H)

Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, WC1E 6BT, United Kingdom.

Charles Eldrid (C)

Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, WC1E 6BT, United Kingdom.

Konstantinos Thalassinos (K)

Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, WC1E 6BT, United Kingdom; Institute of Structural and Molecular Biology, Birkbeck College, University of London, London, WC1E 7HX, United Kingdom.

Jayesh Gor (J)

Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, WC1E 6BT, United Kingdom.

Stephen J Perkins (SJ)

Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, WC1E 6BT, United Kingdom. Electronic address: s.perkins@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH